← back to search

Beow Y. Yeap

Massachusetts General Hospital · US
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Occupational and environmental lung diseases, and Medical Imaging and Pathology Studies.
h-index
85
citations
25,577
works
454
NIH funding
primary concept
email

Recent publications

Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer
JCO Precision Oncology 2024cited by 7position: middledoi
Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial
Nature Cancer 2021cited by 282position: middledoi
Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in <i>ROS1</i> Fusion–Positive Lung Cancer
Clinical Cancer Research 2021cited by 137position: middledoi
Screening and Validation of Molecular Targeted Radiosensitizers
International Journal of Radiation Oncology*Biology*Physics 2021cited by 20position: middledoi
MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer
Clinical Cancer Research 2020cited by 193position: middledoi
A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma
International Journal of Radiation Oncology*Biology*Physics 2020cited by 57position: middledoi
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer
JAMA Oncology 2019cited by 501position: middledoi
Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer
Cancer Discovery 2019cited by 237position: middledoi
An open invitation to join the Pediatric Proton/Photon Consortium Registry to standardize data collection in pediatric radiation oncology
British Journal of Radiology 2019cited by 42position: middledoi
Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma
JAMA Oncology 2018cited by 540position: middledoi
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
Journal for ImmunoTherapy of Cancer 2018cited by 248position: middledoi
Brigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLC
Journal of Thoracic Oncology 2018cited by 82position: middledoi
Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study
The Lancet Oncology 2016cited by 336position: middledoi
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Journal of Clinical Oncology 2015cited by 469position: middledoi
Long-term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas
Journal of Surgical Oncology 2014cited by 241position: middledoi
Quality of life outcomes in proton and photon treated pediatric brain tumor survivors
Radiotherapy and Oncology 2014cited by 124position: middledoi
Clinical, Pathologic, and Biologic Features Associated with <i>BRAF</i> Mutations in Non–Small Cell Lung Cancer
Clinical Cancer Research 2013cited by 368position: middledoi
Desmoid Tumor: Analysis of Prognostic Factors and Outcomes in a Surgical Series
Annals of Surgical Oncology 2012cited by 140position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Thomas F. DeLaney · Dartmouth College5 papers (2012–2018)Torunn I. Yock · Harvard University3 papers (2014–2020)Theodore S. Hong · Harvard University3 papers (2015–2021)Subba R. Digumarthy · Harvard University3 papers (2018–2020)Shannon M. MacDonald · Massachusetts General Hospital3 papers (2014–2020)Alice T. Shaw · Harvard University3 papers (2018–2020)Aaron N. Hata · Harvard University3 papers (2019–2021) · 2 papers (2014–2016)David H. Ebb · Massachusetts General Hospital2 papers (2014–2016)David C. Harmon · Oregon Health & Science University2 papers (2012–2014)Karen J. Marcus · Harvard University2 papers (2016–2020)Ibiayi Dagogo‐Jack · Center for Cancer Research2 papers (2018–2020)Daniel A. Haber · Rambam Health Care Campus2 papers (2019–2024)Lipika Goyal · Stanford Cancer Institute2 papers (2015–2018)Cyril H. Benes · Virginia Commonwealth University2 papers (2020–2021)Mary Huang · Dartmouth College2 papers (2014–2016)Jackie Szymonifka · New York University2 papers (2012–2014)Cristina R. Ferrone · Cambridge University Hospitals NHS Foundation Trust2 papers (2015–2018)Janet E. Murphy · Salk Institute for Biological Studies2 papers (2015–2018)Anna F. Farago · Amgen (United States)2 papers (2018–2019)